Yasuhiko Nishioka (Tokushima, Japan), Oliver Eickelberg (Munich, Germany)
LATE-BREAKING ABSTRACT: Fibroblast conditioned matrix: A new approach to study extracellular matrix (ECM) effects in idiopathic pulmonary fibrosis (IPF) Gali Epstein Shochet (Kfar-Saba, Israel), Gali Epstein Shochet, Lilach Israeli-Shani, David Shitrit
| |
LATE-BREAKING ABSTRACT: Do mesenchymal stromal cells provide an organ-specific tissue niche? – A proteomic matrisome characterization Sara Rolandsson Enes (Lund, Sweden), Sara Rolandsson Enes, Emma Åhrman, Anitha Palani, Oskar Hallgren, Leif Bjermer, Stefan Scheding, Anders Malmström, Johan Malmström, Gunilla Westergren-Thorsson
| |
A role for microRNA-29c in arrested alveolarisation associated with experimental bronchopulmonary dysplasia David Surate Solaligue (Bad Nauheim, Germany), David Surate Solaligue, Diogo Silva, Werner Seeger, Rory Morty
| |
The role of transglutaminase 2 in normal and aberrant late lung development Ivana Mizikova (Bad Nauheim, Germany), Ivana Mizikova, Diogo Silva, Werner Seeger, Rory Morty
| |
Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast Antoine Froidure (Paris, France), Antoine Froidure, Emmeline Marchal-Duval, Mada Ghanem, Laura Gerish, Madeleine Jaillet, Bruno Crestani, Arnaud Mailleux
| |
LSC Abstract – Enhanced expression of alarmins in pulmonary hypertension and fibrosis Aleksandar Petrovic (Beograd, Republic of Serbia), Aleksandar Petrovic, Jan Niklas Schneider, Magorzata Wygrecka, Oleg Pak, Elie El Agha, Norbert Wiessmann, Saverio Bellusci, Djuro Kosanovic, Ralph Theo Schermuly
| |
ATF3 regulates PINK1 transcription in lung epithelial cells of the aging lung Ana Mora (Pittsburgh, United States of America), Marta Bueno, Judith Brands, Rama K. Mallampalli, Ana L. Mora
| |